Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Hofer

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
European Journal of Radiology|May 2, 2009
Non-invasive assessment of hepatic fat accumulation in chronic hepatitis C by 1H magnetic resonance spectroscopyMartin Krssák, Harald Hofer, Fritz Wrba, et al.
Cytokine|June 9, 2005
TGF-beta1 codon 25 gene polymorphism is associated with cirrhosis in patients with hereditary hemochromatosisChristoph H Osterreicher, Christian Datz, Felix Stickel, et al.
Journal of Hepatology|August 15, 2002
Subclinical impairment of brain function in chronic hepatitis C infectionLudwig Kramer, Edith Bauer, Georg Funk, et al.
Antiviral Therapy|December 14, 2011
Intravenous silibinin as 'rescue treatment' for on-treatment non-responders to pegylated interferon/ribavirin combination therapyKaroline Rutter, Thomas-Matthias Scherzer, Sandra Beinhardt, et al.
Ebiomedicine|August 29, 2016
Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B InfectionCarolin Cornelius, Katrin Schöneweis, Fanny Georgi, et al.
Journal of Hepatology|December 15, 2010
Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirinThomas-Matthias Scherzer, Harald Hofer, Albert Friedrich Staettermayer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 23, 2013
Role of FDFT1 polymorphism for fibrosis progression in patients with chronic hepatitis CAlbert F Stättermayer, Karoline Rutter, Sandra Beinhardt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 15, 2011
Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infectionThomas Reiberger, Karoline Rutter, Arnulf Ferlitsch, et al.
Wiener Klinische Wochenschrift|May 6, 2010
[4. Austrian consensus-statement for diagnosis and therapy of hepatitis B 2009]Markus Peck-Radosavljevic, Johann Deutsch, Peter Ferenci, et al.
Wiener Klinische Wochenschrift|September 14, 2017
Efficacy of peginterferon plus ribavirin in patients receiving opioid substitution therapy : Final results of the Austrian PegHope studyMichael Gschwantler, Hermann Laferl, Wolfgang Vogel, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
European Journal of Radiology|May 2, 2009
Non-invasive assessment of hepatic fat accumulation in chronic hepatitis C by 1H magnetic resonance spectroscopyMartin Krssák, Harald Hofer, Fritz Wrba, et al.
Cytokine|June 9, 2005
TGF-beta1 codon 25 gene polymorphism is associated with cirrhosis in patients with hereditary hemochromatosisChristoph H Osterreicher, Christian Datz, Felix Stickel, et al.
Journal of Hepatology|August 15, 2002
Subclinical impairment of brain function in chronic hepatitis C infectionLudwig Kramer, Edith Bauer, Georg Funk, et al.
Antiviral Therapy|December 14, 2011
Intravenous silibinin as 'rescue treatment' for on-treatment non-responders to pegylated interferon/ribavirin combination therapyKaroline Rutter, Thomas-Matthias Scherzer, Sandra Beinhardt, et al.
Ebiomedicine|August 29, 2016
Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B InfectionCarolin Cornelius, Katrin Schöneweis, Fanny Georgi, et al.
Journal of Hepatology|December 15, 2010
Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirinThomas-Matthias Scherzer, Harald Hofer, Albert Friedrich Staettermayer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 23, 2013
Role of FDFT1 polymorphism for fibrosis progression in patients with chronic hepatitis CAlbert F Stättermayer, Karoline Rutter, Sandra Beinhardt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 15, 2011
Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infectionThomas Reiberger, Karoline Rutter, Arnulf Ferlitsch, et al.
Wiener Klinische Wochenschrift|May 6, 2010
[4. Austrian consensus-statement for diagnosis and therapy of hepatitis B 2009]Markus Peck-Radosavljevic, Johann Deutsch, Peter Ferenci, et al.
Wiener Klinische Wochenschrift|September 14, 2017
Efficacy of peginterferon plus ribavirin in patients receiving opioid substitution therapy : Final results of the Austrian PegHope studyMichael Gschwantler, Hermann Laferl, Wolfgang Vogel, et al.
Pageof 8